IRONWOOD PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 87.2% | 49.8% | 46.9% |
| FY2022 | 26.8% | 16.7% | 15.9% |
| FY2023 | 289.4% | 289.4% | -212.8% |
| FY2024 | -0.3% | -0.3% | 0.3% |
| FY2025 | -9.2% | -9.2% | 6.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 87.2% | 49.8% | 46.9% |
| FY2022 | 26.8% | 16.7% | 15.9% |
| FY2023 | 289.4% | 289.4% | -212.8% |
| FY2024 | -0.3% | -0.3% | 0.3% |
| FY2025 | -9.2% | -9.2% | 6.1% |